RxDoctor Payments Data

Christina Swallow, MD

Urogynecology and Reconstructive Pelvic Surgery · Saint Paul, MNNPI 1083102982

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Boston Scientific at 32.1% of the total. Reporting peaked in 2022 at $2,205 and has fallen 99.4% since, to $13 in 2025.

$3,964in general payments, 2019–2025

Across 24 payments — averaging $165.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Coloplast$1K
  • Intuitive Surgical$1K
  • Coopersurgical, Inc.$270
  • Medtronic$188
  • Applied Medical Resources Corporation$38

What the payments were for

  • Consulting fees$2707%
  • Travel & lodging$1,58640%
  • Food & beverage$1,10828%
  • Education$1,00025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,964 in reported general payments places this provider in the 65th percentile of 22 urogynecology and reconstructive pelvic surgery providers in Minnesota.

See all urogynecology and reconstructive pelvic surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$66,208
Medicare patients
148
Services billed
1,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron246$177,247
GemtesaVibegron82$60,385
Estradiol125$7,423
Mirabegron ErMirabegron11$6,306
Trospium Chloride ErTrospium Chloride35$6,294
Trospium Chloride85$4,362
Methenamine Hippurate13$1,465
Tolterodine Tartrate ErTolterodine Tartrate22$1,310
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst35$674
Solifenacin Succinate15$391
Oxybutynin Chloride ErOxybutynin Chloride41$353
Cephalexin43$191
Ibuprofen15$153
Clobetasol Propionate11$117
Oxycodone Hcl43$93

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →